Forecast: Head and Neck Cancer.
By Dominique Fontanilla, Senior Analyst
23 November 2015
I joined Datamonitor Healthcare’s disease team in 2014 having previously worked as a biochemistry postdoctoral fellow ...
Read full bio
Datamonitor Healthcare has used a patient-based forecasting methodology to estimate the total size of the branded squamous cell carcinoma of the head and neck (SCCHN) market within the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK) from 2015 to 2024.
The full forecast provides you with estimates of total sales and patient numbers of the branded squamous cell head and neck cancer market. It also incorporates the anticipated launches of pipeline therapies in development for this disease.
Fill out the form now to download your exclusive sneak peek into this market leading report >>
If you’re already a subscriber to Datamonitor Healthcare, click here to access the full report.